Literature DB >> 12882770

How sensitive to clinical change are ETDRS logMAR visual acuity measurements?

Daniel A Rosser1, Simon N Cousens, Ian E Murdoch, Fred W Fitzke, David A H Laidlaw.   

Abstract

PURPOSE: To determine the sensitivity to change and specificity achieved when published test-retest variability (TRV) data are used to determine whether measured changes in ETDRS logarithm of the minimum angle of resolution (logMAR) visual acuity reflect true clinical change or are attributable to measurement error alone.
METHODS: Various degrees of change in visual acuity were simulated in a group of normal subjects by adjusting test difficulty through manipulation of viewing distance. Sensitivity to simulated change and specificity were determined with change criteria derived from published Bland-Altman 95% ranges for TRV.
RESULTS: The relationship between viewing distance and measured acuity was as predicted theoretically. Simulated acuity change of 0.2 logMAR (two lines of letters) or greater can be reliably distinguished from no change (both sensitivity and specificity >95%) with the ETDRS chart, but a change of 0.1 logMAR or less cannot.
CONCLUSIONS: The use of 95% ranges for TRV to establish the smallest measured visual acuity change that can be reliably detected ensures a high specificity but does not take account of sensitivity. Use of change criteria derived from published 95% ranges results in a sensitivity of approximately 50% (assuming identical levels of TRV). Sensitivity may be improved by using a change criterion that is smaller than the minimum change sought, providing the change criterion is still at least as large as the 95% range for TRV, so that specificity is maintained. Reducing TRV allows smaller changes in acuity to be reliably detected.

Mesh:

Year:  2003        PMID: 12882770     DOI: 10.1167/iovs.02-1100

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  53 in total

1.  The influence of varying the number of characters per row on the accuracy and reproducibility of the ETDRS visual acuity chart.

Authors:  Reuben R Shamir; Yael G Friedman; Leo Joskowicz; Michael Mimouni; Eytan Z Blumenthal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-07       Impact factor: 3.117

2.  Repeatability of visual function measures in age-related macular degeneration.

Authors:  Tariq Aslam; Sajjad Mahmood; Konstantinos Balaskas; Niall Patton; Rajeev G Tanawade; Shi Zhuan Tan; Stephen A Roberts; Jeremy Parkes; Paul N Bishop
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-25       Impact factor: 3.117

3.  Testing vision testing: quantifying the effect of movement on visual acuity measurement.

Authors:  L P Tidbury; A R O'Connor
Journal:  Eye (Lond)       Date:  2014-10-24       Impact factor: 3.775

4.  A comparison of contrast sensitivity and sweep visual evoked potential (sVEP) acuity estimates in normal humans.

Authors:  William H Ridder
Journal:  Doc Ophthalmol       Date:  2019-08-14       Impact factor: 2.379

5.  Visual acuity of pseudophakic patients predicted from in-vitro measurements of intraocular lenses with different design.

Authors:  Fidel Vega; Maria S Millán; Nuria Garzón; Irene Altemir; Francisco Poyales; Jose Manuel Larrosa
Journal:  Biomed Opt Express       Date:  2018-09-17       Impact factor: 3.732

6.  Ganglion cell loss in relation to visual disability in multiple sclerosis.

Authors:  Scott D Walter; Hiroshi Ishikawa; Kristin M Galetta; Reiko E Sakai; Daniel J Feller; Sam B Henderson; James A Wilson; Maureen G Maguire; Steven L Galetta; Elliot Frohman; Peter A Calabresi; Joel S Schuman; Laura J Balcer
Journal:  Ophthalmology       Date:  2012-02-23       Impact factor: 12.079

7.  Monitoring of Diabetic Retinopathy in relation to Bariatric Surgery: a Prospective Observational Study.

Authors:  Troels Brynskov; Caroline Schmidt Laugesen; Annette Lykke Svenningsen; Andrea Karen Floyd; Torben Lykke Sørensen
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

8.  Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.

Authors:  Zane S Schnurman; Teresa C Frohman; Shin C Beh; Darrel Conger; Amy Conger; Shiv Saidha; Steven Galetta; Peter A Calabresi; Ari J Green; Laura J Balcer; Elliot M Frohman
Journal:  Neurology       Date:  2014-04-30       Impact factor: 9.910

9.  Assessing visual acuity across five disease types: ETDRS charts are faster with clinical outcome comparable to Landolt Cs.

Authors:  Simone Koenig; Felix Tonagel; Ulrich Schiefer; Michael Bach; Sven P Heinrich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-28       Impact factor: 3.117

10.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.